Stuart Hazeldine
Impact in
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
-
- RNA Interference and Gene Delivery
- Polyamine Metabolism and Applications
- Epigenetics and DNA Methylation
- Advanced biosensing and bioanalysis techniques
- Histone Deacetylase Inhibitors Research
Papers in
-
- RNA Interference and Gene Delivery 5
- Cancer therapeutics and mechanisms 5
- Epigenetics and DNA Methylation 4
-
- Synthesis and Biological Evaluation 5
- Quinazolinone synthesis and applications 3
- Co-authors
- Jerome P. Horwitz (11 shared papers)Thomas H. Corbett (10 shared papers)Juiwanna Kushner (9 shared papers)Kathryn White (9 shared papers)Lisa Polin (8 shared papers)David Oupický (6 shared papers)Yu Zhu (5 shared papers)Patrick M. Woster (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Bioorganic & Medicinal Chemistry (3 papers)Investigational New Drugs (2 papers)Advanced Healthcare Materials (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Stuart Hazeldine
23 papers receiving 819 citations
Peers
Comparison fields: 5 of 87
- Organic Chemistry 302
- Molecular Biology 444
- Toxicology 17
- Biochemistry 32
- Oncology 92
Countries citing papers authored by Stuart Hazeldine
This map shows the geographic impact of Stuart Hazeldine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hazeldine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hazeldine more than expected).
Fields of papers citing papers by Stuart Hazeldine
This network shows the impact of papers produced by Stuart Hazeldine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hazeldine. The network helps show where Stuart Hazeldine may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Hazeldine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 110 | |
| 2 | 2001 | 105 | |
| 3 | 2012 | 81 | |
| 4 | 2002 | 70 | |
| 5 | 2012 | 64 | |
| 6 | 2004 | 56 | |
| 7 | 2008 | 46 | |
| 8 | 2014 | 39 | |
| 9 | 2011 | 32 | |
| 10 | 2006 | 27 | |
| 11 | 2007 | 25 | |
| 12 | 2005 | 25 | |
| 13 | 2014 | 22 | |
| 14 | 2002 | 22 | |
| 15 | 2005 | 21 | |
| 16 | 2012 | 19 | |
| 17 | 2010 | 19 | |
| 18 | 2002 | 15 | |
| 19 | 2012 | 15 | |
| 20 | 2011 | 14 |
About Stuart Hazeldine
Stuart Hazeldine is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Genetics and Immunology, having authored 23 papers that have together received 844 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (5 papers), Epigenetics and DNA Methylation (4 papers), Quinazolinone synthesis and applications (3 papers), Immunotherapy and Immune Responses (3 papers), Chemokine receptors and signaling (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Organic Chemistry (302 citations), Molecular Biology (444 citations), Toxicology (17 citations), Biochemistry (32 citations) and Oncology (92 citations). Stuart Hazeldine has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Jerome P. Horwitz, Thomas H. Corbett, Juiwanna Kushner, Kathryn White, Lisa Polin, David Oupický, Yu Zhu, Patrick M. Woster, Jing Li and Chunying Li. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Investigational New Drugs, Advanced Healthcare Materials and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.